Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis.
Energy-dependent intestinal calcium absorption is important for the maintenance of calcium and bone homeostasis, especially when dietary calcium supply is restricted. The active form of vitamin D, 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], is a crucial regulator of this process and increases the expression of the transient receptor potential vanilloid 6 (Trpv6) calcium channel that mediates calcium transfer across the intestinal apical membrane. Genetic inactivation of Trpv6 in mice (Trpv6(-/-)) showed, however, that TRPV6 is redundant for intestinal calcium absorption when dietary calcium content is normal/high and passive diffusion likely contributes to maintain normal serum calcium levels. On the other hand, Trpv6 inactivation impaired the increase in intestinal calcium transport following calcium restriction, however without resulting in hypocalcemia. A possible explanation is that normocalcemia is maintained at the expense of bone homeostasis, a hypothesis investigated in this study. In this study, we thoroughly analyzed the bone phenotype of Trpv6(-/-) mice receiving a normal (approximately 1%) or low (approximately 0.02%) calcium diet from weaning onwards using micro-computed tomography, histomorphometry and serum parameters. When dietary supply of calcium is normal, Trpv6 inactivation did not affect growth plate morphology, bone mass and remodeling parameters in young adult or aging mice. Restricting dietary calcium had no effect on serum calcium levels and resulted in a comparable reduction in bone mass accrual in Trpv6(+/+) and Trpv6(-/-) mice (-35% and 45% respectively). This decrease in bone mass was associated with a similar increase in bone resorption, whereas serum osteocalcin levels and the amount of unmineralized bone matrix were only significantly increased in Trpv6(-/-) mice. Taken together, our findings indicate that TRPV6 contributes to intestinal calcium transport when dietary calcium supply is limited and in this condition indirectly regulates bone formation and/or mineralization.
Lieben
L
L
Laboratory of Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Leuven, B-3000, Belgium.
Benn
B S
BS
Ajibade
D
D
Stockmans
I
I
Moermans
K
K
Hediger
M A
MA
Peng
J B
JB
Christakos
S
S
Bouillon
R
R
Carmeliet
G
G
D000375:Aging / Q000187:drug effects / Q000473:pathology; D000818:Animals; D016723:Bone Remodeling / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism*; D002118:Calcium / Q000097:blood / Q000378:metabolism*; D015220:Calcium Channels / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D002136:Calcium, Dietary / Q000494:pharmacology*; D004386:Duodenum / Q000187:drug effects / Q000378:metabolism; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D006706:Homeostasis / Q000187:drug effects*; D007408:Intestinal Absorption / Q000187:drug effects*; D015640:Ion Channel Gating / Q000187:drug effects; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects; D010710:Phosphates / Q000097:blood; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D050916:TRPV Cation Channels / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*
D015220:Calcium Channels; D002136:Calcium, Dietary; D010710:Phosphates; D012333:RNA, Messenger; D050916:TRPV Cation Channels; C446923:Trpv6 protein, mouse; D002118:Calcium
Endocrinology. 1998 Oct;139(10):4391-6
9751523
Am J Physiol. 1998 Feb;274(2):G389-96
9486194
Arch Biochem Biophys. 2004 Dec 15;432(2):152-66
15542054
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7498-503
11416220
J Clin Invest. 2006 Dec;116(12):3150-9
17099775
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13324-9
11687634
J Bone Miner Res. 2003 Jul;18(7):1217-26
12854831
Am J Clin Nutr. 2004 Oct;80(4):998-1002
15447911
J Biol Chem. 1999 Aug 6;274(32):22739-46
10428857
J Bone Miner Res. 1997 Jun;12(6):922-8
9169351
Mol Biol Cell. 2008 May;19(5):1912-21
18287530
Lancet. 1970 Sep 12;2(7672):535-7
4195202
Biochem Biophys Res Commun. 2001 Dec 21;289(5):1287-94
11741335
Endocrinology. 2008 Jun;149(6):3196-205
18325990
Am J Clin Nutr. 1958 Sep-Oct;6(5):459-65
13594869
Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1193-7
19779013
Baillieres Clin Endocrinol Metab. 1997 Jul;11(2):341-65
9403126
Endocrinology. 2003 Sep;144(9):3885-94
12933662
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17507-12
16291808
J Bone Miner Res. 2007 Feb;22(2):274-85
17129178
J Pediatr. 1992 Nov;121(5 Pt 1):803-8
1331389
Arch Biochem Biophys. 2005 May 1;437(1):51-8
15820216
J Bone Miner Res. 1987 Dec;2(6):595-610
3455637
Am J Physiol Gastrointest Liver Physiol. 2003 Jul;285(1):G78-85
12620887
Arch Biochem Biophys. 2003 Dec 1;420(1):194-200
14622990
Q J Med. 1975 Jul;44(175):505-21
1178820
Endocr Rev. 2008 Oct;29(6):726-76
18694980
J Bone Miner Res. 1988 Feb;3(1):37-45
3264993
Nat Genet. 1997 Aug;16(4):391-6
9241280
Cell Calcium. 2003 May-Jun;33(5-6):509-18
12765696
Am J Physiol. 1980 Nov;239(5):E322-7
7435610
J Clin Invest. 2006 May;116(5):1230-42
16614757
Arch Biochem Biophys. 2007 Apr 15;460(2):227-32
17224126
J Clin Invest. 1986 May;77(5):1661-7
3009551
J Endocrinol. 1989 Jan;120(1):143-51
2783957
J Am Soc Nephrol. 2003 Nov;14(11):2731-40
14569082
Am J Physiol Gastrointest Liver Physiol. 2001 Feb;280(2):G285-90
11208552
J Clin Invest. 1979 Sep;64(3):729-36
468987
Bone. 2003 Apr;32(4):332-40
12689675
J Bone Miner Res. 2000 Aug;15(8):1510-6
10934649